peptide 1 glp 1 Glucagon-like peptide-1 (GLP-1) receptor agonists are incretin analogues that promote glucose-mediated insulin release and are used to treat type 2 diabetes mellitus and #obesity. GLP-1 receptor agonists and GLP-1 and glucose-dependent insulinotropic GLP-1 | Pancreapedia

Whether in the form of an oral medication or an injection, GLP-1s still work by slowing gastric emptying to help you feel fuller sooner and longer, making you likely to eat less

It has to translocate

This can help prevent your stomach from becoming too full and can reduce the chances of nausea

Further reinforcing this early and rapid inflammation reduction is that a lab measure called hsCRP, or high sensitivity C-reactive protein, was significantly reduced at 4 weeks as well, when patients had only lost 2.7% of their body weight

For the GLP-1 receptor agonists, the pooled event rates ranged from 1.6 to 2.7 per 1,000 patient-years